Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

Corporate Breaking News

Home : Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

Dec 06 2020	Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers
WASHINGTON, Dec. 5, 2020 /PRNewswire/ -- Three studies being presented during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers....


Source:https://www.prnewswire.com:443/news-releases/genome-editing-and-cellular-therapies-show-promise-for-treating-blood-disorders-cancers-301186839.html

Related News
» Rick Durkee, LUTCF® authors a new book - Modern Retirement Strategies: The Definitive Guide to Retiring Well » AbbVie Presents Extended Follow-Up Data for Fixed Duration Treatment VENCLEXTAÂ®/VENCLYXTOÂ® (venetoclax) in Chronic Lymphocytic Leukemia (CLL)